These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 553643)

  • 1. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
    Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
    Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacodynamic comparison of propranolol and verapamil in exertion stenocardia].
    Sumarokov AB; Romakov AIu; Sagirov AM; Iurkova VB; Mazur NA
    Klin Med (Mosk); 1984 Mar; 62(3):42-6. PubMed ID: 6716929
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
    Duarte GM; Ribeiro LG; Coelho W; Thevenard R; Souza PJ; Gonçalves MA; Carneiro RD; Luna RL
    Arq Bras Cardiol; 1976 Aug; 29(4):338-45. PubMed ID: 1008726
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 5. [Exertion-electrocardiographic and hemodynamic studies with oral verapamil in chronic ischemic heart disease].
    Assmann I; Schwela H; Oltmanns G; Fiehring H
    Z Gesamte Inn Med; 1978 May; 33(10):300-3. PubMed ID: 98925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of isoptin on intrahepatic and central hemodynamics in ischemic heart disease].
    Komissarov VA
    Klin Med (Mosk); 1987 Sep; 65(9):64-7. PubMed ID: 3695314
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term administration of verapamil in coronary disease].
    Tkaczewski W; Goch JH; Bala T; Kuklewicz C
    Pol Tyg Lek; 1977 Oct; 32(44):1719-21. PubMed ID: 917918
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of verapamil on major events in patients with exercise-induced ischemia recovering from acute myocardial infarction: a review. The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S30-2. PubMed ID: 1725914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].
    Savvateev KL; Shinbaeva NA; Vygodin VA; Nikolenko SA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):64-70. PubMed ID: 7259869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of therapeutic effects of Verapamil by means of an exercise test].
    Goch JH; Rec A; Bala T
    Pol Tyg Lek; 1975 Sep; 30(36):1497-8. PubMed ID: 1161614
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
    Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immediate action of oxyphedrin as evaluated using the exertion test in coronary patients].
    Velasco Rami JA; Tormo Alfonso V; Roda Nicolas J; Serra Sister E
    Rev Esp Cardiol; 1977; 30(1):17-21. PubMed ID: 854620
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
    Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of drugs upon exercise tests in coronary insuffiency.
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():79-81. PubMed ID: 329813
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 17. [Verapamil in a single dose, evaluation by means of the ergometric test].
    Pereira MH; Brito FS; Pereira CB; Lion MF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():83-94. PubMed ID: 889475
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dose-effect dependence after taking calcium antagonists in exertion stenocardia patients].
    Shinbaeva NA; Vygodin VA; Martsevich SIu; Metelitsa VI
    Ter Arkh; 1983; 55(3):122-7. PubMed ID: 6857524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tolerance for the antianginal effect of nitrates. Approaches to its study].
    Martsevich SIu; Shakarova SSh; Metelitsa VI; Strel'tsov AA; Vygodin VA
    Ter Arkh; 1984; 56(9):46-50. PubMed ID: 6515547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.